Pre-screening device for sleep apnea
Sensirion is the leading sensor supplier for OSA (obstructive sleep apnea ) therapy devices such as CPAPs and has an outstanding record in the field of sleep quality management. In 2016, Frost & Sullivan revealed that only one out of five Americans with obstructive sleep apnea are properly diagnosed. A shocking 23.5 out of 29.4 million Americans with OSA are undiagnosed and remain untreated which amounts to tremendous economic costs. The authors estimate that over $10 billion could be saved every year if all Americans who suffer from OSA were properly diagnosed and treated. Sensirion's tiny sensors enable inexpensive and convenient pre-screening at home due to their unmatched sensitivity. One idea how such a pre-screening device could look like can be found on our developers Website.
Become Part of the Sensirion-World
With Sensirion's preference-based newsletter, we provide you with exactly the information you need. Let us know what content is of interest to you and secure access to exclusive knowledge. Sensirion's newsletters offer insights into current topics, new products, trade fairs and the company as a workplace.